APEN Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 Apr 2023 @ 16:00):

Stats
Today's Volume	1.64M
Average Volume	1.33M
Market Cap	579.72M
EPS	$0 ( 2024-03-28 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9.43
ATR14	$0.0390 (0.39%)

Insider Trading

Date	Person	Action	Amount	type
2023-04-04	Mcgaughy R Kent Jr	Sell	400 675	Common Stock
2023-04-04	Mcgaughy R Kent Jr	Sell	38 667	Stock Option (Right to Buy)
2023-04-04	Cpmg Inc	Sell	400 675	Common Stock
2023-04-04	Barr John R	Sell	44 082	Common Stock
2023-04-04	Barr John R	Sell	5 271	Non-Qualified Stock Option (right to buy)

INSIDER POWER
-15.38
Last 98 transactions
Buy: 5 638 377 \| Sell: 4 907 735

Volume Correlation

Long: 0.13 (neutral)

Short: 0.00 (neutral)

Signal:(66.037) Neutral

Apollo Endosurgery Inc Correlation

10 Most Positive Correlations
NETE	0.955
MDGL	0.952
RAVN	0.922
SRAC	0.9
UFPT	0.886
AGYS	0.883
NRIM	0.882
PODD	0.879
TSBK	0.879
AMRB	0.875

10 Most Negative Correlations
BVXV	-0.948
SNPX	-0.938
SVAC	-0.935
FREQ	-0.934
PAIC	-0.933
SVOK	-0.928
TSP	-0.923
ALTM	-0.922
ZI	-0.919
SGRP	-0.917

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Apollo Endosurgery Inc Correlation - Currency/Commodity

-0.44
( neutral )

-0.21
( neutral )

-0.43
( neutral )

-0.65
( moderate negative )

0.47
( neutral )

-0.06
( neutral )

Apollo Endosurgery Inc Financials

Annual	2022
Revenue:	$76.86M
Gross Profit:	$42.43M (55.20 %)
EPS:	$-0.980

Q4	2022
Revenue:	$21.31M
Gross Profit:	$11.36M (53.28 %)
EPS:	$-0.320

Q3	2022
Revenue:	$19.57M
Gross Profit:	$10.74M (54.86 %)
EPS:	$-0.280

Q2	2022
Revenue:	$19.31M
Gross Profit:	$10.96M (56.76 %)
EPS:	$-0.260

Financial Reports:

No articles found.

Apollo Endosurgery Inc

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.